ELAVL1 and bone inflammation disease: In inflammatory bone diseases such as rheumatoid arthritis, pro-inflammatory cytokines and stress signaling pathways have been reported to regulate HuR expression and subcellular localization, impacting skeletal homeostasis [36,37].